FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Cardiac Ablation Percutaneous Catheter

PMA: P020045 · Supplement: S101 · Decision Aug 24, 2022
Classifications
1
FEI Numbers
52
Registration Numbers
52

Basic Information

Device Name
Cardiac Ablation Percutaneous Catheter
Trade Name
Freezor TM Cardiac Cryoablation Catheter
PMA Number
P020045
Supplement Number
S101
Device Class
FDA Class 3
Product Code
LPB
Generic Name
Cardiac ablation percutaneous catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
August 24, 2022
Date Received
July 25, 2022
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Manufacturing and supplier changes to the female coaxial connector and female coaxial fitting of the Arctic Front Advance (AFA), Arctic Front Advance Pro (AFA Pro), Freezor, Freezor Xtra, and Freezor MAX cryoablation catheters.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LPB Cardiac Ablation Percutaneous Catheter